PharmaMatch has direct contacts with all the major players in the European pharmaceutical market, and has a proven track record for successfully selling active pharmaceutical ingredients and generic dossiers.

Thanks to in-depth market knowledge and long-term client relationships, PharmaMatch has excellent insight into potential customers' portfolio-and therefore the products to be licensed - whether they are blockbusters, niche products or mature generic products. Our sales managers cover the entire EMEA region.

To date, we have concluded long-term agreements with all relevant generic companies in the EU, selling over 200 seperate dossiers. PharmaMatch has started the development of an OTC portfolio, for which Paracetamol and Ibuprofen dossiers have now been registered on the basis of largescale production.